Newlink Genetics (NLNK) Posts Q3 Loss of 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Baird Says Time is Right to Own NewLink Genetics (NLNK)
October 31, 2012 1:49 PM EDTBaird reiterated an Outperform rating on NewLink Genetics (NASDAQ: NLNK) and raised its price target to $20.00 (from $17.00).
"Though the quarterly print was uneventful, we continue to like NLNK for its significant pipeline potential, with first HyperAcute Pancreas Phase III interim look in... More



